Bioavailability is the amount of a therapeutically active substance that has reached the systemic bloodstream and has become available at the place of application of its action. Bioavailability is also one of the essential parameters used in pharmacokinetics, taken into account when calculating the dosage regimen for routes of administration of drugs other than [...]
A. V. Matveev, E. A. Egorova, A. E. Krasheninnikov, E. I. Konyaeva https://doi.org/10.30895/2312-7821-2021-9-2-95-102 ABSTRACT According to international epidemiological studies, about 80% of women have to use medicinal products during pregnancy, mainly during the first weeks of organogenesis in the case of an unplanned pregnancy, and for the treatment of chronic diseases or acute conditions [...]
Matveev A.V., Krasheninnikov A.E., Egorova E.A., Konyaeva E.I., Bekirova E.Yu.National Scientific Center for Pharmacovigilance, S.I. Georgievsky Medical Academy of the Crimean Federal University named after V.I. Vernadsky, Moscow, Simferopol. At the present stage of healthcare development, the study of gender peculiarities of the onset and course of various diseases, as well as the variability [...]
Macrolides are one of the groups of antibacterial drugs that are widely used to treat nosocomial infections. This review focuses on the safety of erythromycin. The main attention is paid to the study of prokinetic properties of erythromycin, its cardiotoxicity, and fetotoxicity.
Bioequivalence (pharmacokinetic equivalence) is the degree of similarity of a pharmaceutically equivalent drug to a reference drug (usually a generic drug to an original proprietary drug). Determined experimentally, in vivo. As you know, after the development and registration (authorization) of a medicinal product, the product enters the pharmaceutical market. The developer is the owner of [...]
